496 results on '"Yin, Ji‐Ye"'
Search Results
2. A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma
3. Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity
4. eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin
5. CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
6. Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
7. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy
8. A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma
9. Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer
10. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
11. Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective
12. The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage
13. HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
14. Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
15. Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity
16. Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer
17. Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer
18. eIF3a: A new anticancer drug target in the eIF family
19. Precision dosing of warfarin: open questions and strategies
20. The IDO genetic polymorphisms and postpartum depressive symptoms: an association study in Chinese parturients who underwent cesarean section
21. Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer
22. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women
23. Epidemiological and clinical features of pediatric COVID-19
24. The role of CSDE1 in translational reprogramming and human diseases
25. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population
26. Data from Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
27. Supplementary Tables S1-S2 from Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
28. Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients
29. A simple method for the formalin fixation of lungs in toxicological pathology studies
30. Defined Surface Physicochemical Cues Inhibit M1 Polarization of Human Macrophages Using Colloidal Self-Assembled Patterns.
31. Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response
32. Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems
33. Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
34. Association of ABCB1 Polymorphisms With the Efficacy of Ondansetron in Chemotherapy-induced Nausea and Vomiting
35. JAZF1 regulates visfatin expression in adipocytes via PPARα and PPARβ/δ signaling
36. Possible Strategies to Make Warfarin Dosing Algorithm Prediction More Accurately in Patients With Extreme Dose
37. Age‐related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum‐based chemotherapy
38. eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response
39. Abstract LB548: Genomic analysis of antineoplastic drug-related genetic variations based on large-scale population sequencing
40. Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment
41. Association of variations in the Fanconi anemia complementation group and prognosis in Non–small cell lung cancer patients with Platinum-based chemotherapy
42. B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
43. Sequential Whole Exome Sequencing Reveals Somatic Mutations Associated with Platinum Response in NSCLC
44. MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
45. eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer
46. Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals
47. Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility
48. The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
49. Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
50. The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.